TKT and hepatocellular carcinoma: The mRNA level of TKT in each of the metastatic HCC cell lines, including HCCLM3, MHCC97H and MHCC97L, was significantly higher than in any of the non-metastatic cells, including PLC/PRE/5, Huh7, Hep3B and HepG2.